Degradation control can increase and decrease the period. by Angela Relógio (193817)

“…The graphic represents the period as a function of the degradation rate. We marked 2 points (B, C) in the decreasing period region of the graphic and 2 points (D, E) in the increasing period region. …”

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Adhesion strength is decreased in NEDD9−/− MEFs. by Jessie Zhong (171961)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

IR decreases but does not arrest ATC growth. by Vlad C. Sandulache (515406)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Decreased H4R expression in GCs. by Chao Zhang (51048)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Deletion of the 55C <i>Bom</i> genes impairs resistance to <i>E</i>. <i>faecalis</i> infection rather than tolerance. by Alexa W. Clemmons (247908)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”